Chip Stocks Achieve Best Quarterly Performance in History Amid AI Demand Concerns
On July 1, chip stocks recorded their best quarterly performance in history, continuing a strong upward trend this year driven by robust demand for artificial intelligence devices. However, following recent stock price fluctuations, investors are beginning to question how long this rally can last. CJ Muse, Senior Managing Director and Technology Industry Analyst at Cantor Fitzgerald, stated, "The main theme over the past six months has been the market's comprehensive bet on AI infrastructure, but now people are starting to ask whether this is sustainable and whether we should be concerned." The Philadelphia Semiconductor Index rose 3.9% on Tuesday, with a second-quarter increase of 88%, marking its best quarterly performance ever. The index has risen 101% in the first half of the year, on track for its best annual performance in history. In contrast, the tech-heavy Nasdaq 100 index rose 28% in the second quarter, and the S&P 500 index increased by 15%, both achieving their best quarterly performance since 2020, but still significantly lagging behind chip stocks. However, just as the market began to celebrate, last week's sell-off sounded alarm bells for investors. As Wall Street increasingly questions whether chip demand can be sustained, the Philadelphia Semiconductor Index fell 7.9% last week, recording its largest weekly decline since April 2025. On Monday, the index briefly dropped 3.2% during trading but ultimately closed up 3.8%, indicating heightened volatility.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
Blackstone (BX.US) injects up to $1.5 billion, providing fresh ammunition for Pfizer (PFE.US) in the weight-loss drug race
Pfizer announced on Wednesday that it has reached an agreement with Blackstone to obtain up to $1.5 billions in funding to support the development of its experimental monthly obesity treatment drug.
Bernstein Downgrades Nvidia Rating and Target Price

Google (GOOGL.US) DeepMind launches AlphaGenome 2: Capable of decoding DNA cells with nearly double the mutation identification capacity
Google DeepMind has released its AI model AlphaGenome 2, which is trained on maps of over 100 millions of cells and has nearly double the ability of its predecessor in identifying gene expression variations.

The White House did not intervene in the decision-making of Nvidia's board of directors.
